APA (7th ed.) Citation

Shi, D., Gao, L., Wan, X., Li, J., Tian, T., Hu, J., . . . Zhou, X. (2022). Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: A multicenter study in China. BMC Medicine, 20(1), 1. https://doi.org/10.1186/s12916-022-02683-9

Chicago Style (17th ed.) Citation

Shi, Di, et al. "Clinicopathologic Features and Abnormal Signaling Pathways in Plasmablastic Lymphoma: A Multicenter Study in China." BMC Medicine 20, no. 1 (2022): 1. https://doi.org/10.1186/s12916-022-02683-9.

MLA (9th ed.) Citation

Shi, Di, et al. "Clinicopathologic Features and Abnormal Signaling Pathways in Plasmablastic Lymphoma: A Multicenter Study in China." BMC Medicine, vol. 20, no. 1, 2022, p. 1, https://doi.org/10.1186/s12916-022-02683-9.